Navigation Links
Ecstasy Use During Pregnancy May Harm Fetus: Study
Date:2/28/2012

TUESDAY, Feb. 28 (HealthDay News) -- Taking the hallucinogen ecstasy during pregnancy may harm the health of the fetus and lead to poorer motor control in infants, a new study suggests.

Researchers asked 96 British women about their substance-abuse history before and during pregnancy. The women were taking part in the University of East London Drugs and Infancy Study, which looks at recreational drug use among pregnant women. Most of the women reported taking a range of illegal drugs both before and during pregnancy.

Infant growth, motor control and brain development were assessed at birth and when babies were 4 months old.

Infants born to mothers who used ecstasy during pregnancy had worse motor control and poorer hand-eye coordination at 4 months than babies whose mothers didn't use the drug. Other problems among the ecstasy-exposed group included an impaired ability to balance their heads, sit up without support or roll from their back on to their side.

"The potential harmful effects of ecstasy exposure on prenatal and infant development have long been a concern," study author Lynn Singer, a professor of environmental health sciences, pediatrics and psychiatry at Case Western Reserve University School of Medicine, in Cleveland, said in a university news release.

"The drug's negative effects are particularly risky for pregnant women, who may use the drug without being aware of their condition," she added.

The study also found that ecstasy was associated with more male births, suggesting that the drug may impact "chemical signaling that determines a baby's gender."

The study, funded by the U.S. National Institute on Drug Abuse, is published in the Feb. 28 issue of Neurotoxicology and Teratology.

The authors note that ecstasy (whose chemical name is "3,4-methylenedioxymethamphetamine" or MDMA) is one of the most popular illegal drugs in the world.

Ecstasy can deplete a user's levels of serotonin, a neurotransmitter that is a key regulator of mood, sleep and anxiety, according to the researchers. Serotonin is important during early fetal brain development, so altering levels of the neurotransmitter may have a long-term impact on babies, researchers said.

The study authors will continue to track infants through their first 18 months of life.

While the study found an association between ecstasy use and negative impacts on fetal and infant development, it did not prove causation.

More information

For more on ecstasy, visit the U.S. National Institute on Drug Abuse.

-- Alan Mozes

SOURCE: Neurotoxicology and Teratology, Feb. 27, 2012, news release.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Ecstasy May Cause Long-Term Changes in Brain Chemistry
2. Ecstasy Use May Make Brain Less Efficient
3. Ecstasy associated with chronic change in brain function
4. Long-Term Ecstasy Users at Risk for Brain Damage, Study Warns
5. New study finds no cognitive impairment among ecstasy users
6. Does Club Drug Ecstasy Have Therapeutic Value?
7. Use of Marijuana, Ecstasy, Methamphetamine on Rise in U.S.
8. Researchers Use Ecstasy to Treat PTSD
9. Women decrease condom use during freshman year of college, study finds
10. Blood Test Detects Down Syndrome During Pregnancy
11. New Blood Thinner May Prevent Blood Clots During Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... ... July 23, 2017 , ... Scientists from the University of Exeter ... of high-intensity, weight-bearing activity equivalent to a medium-paced run for pre-menopausal women, or a ... who specializes in total spine care, I understand the importance exercise can play on ...
(Date:7/23/2017)... (PRWEB) , ... July 23, 2017 , ... ... has joined Florida Pain Relief Group – Melbourne, a practice owned by Physician ... certification in interventional pain management, Dr. Stern also is certified in pediatrics, emergency ...
(Date:7/22/2017)... ... July 22, 2017 , ... The arthroscopic ... repairs the opportunity to return to sports and jobs that require heavy physical ... Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. , “We studied ...
(Date:7/21/2017)... ... July 21, 2017 , ... Roderick Crabbe ... services to families and business owners in northern Florida, is joining the First ... support to area adults with developmental challenges. , The First Coast YMCA offers ...
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed in the second ... of hospital acquisitions rose to 23 in the second quarter, up 15% from the ... the 20 announced deals in the year-ago second quarter. Only four of the transactions ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/5/2017)... July 5, 2017 Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... has received approval from the Israel Securities Authority to dual-list ... Oramed common stock will commence trading on the TASE on ... current market capitalization of the Company, it is expected that ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: